Study Design: A level III retrospective comparative study. Objective: Assess the clinical efficacy of somatosensory-evoked potential (SSEP) spinal cord monitoring (SCM) in Rett syndrome patients undergoing scoliosis surgery. Summary of Background Data: The role of SCM in neuromuscular scoliosis is less accurate compared with idiopathic scoliosis because of the nature of the neuropathic or myopathic disorder. Currently, there are no studies that have specifically addressed the accuracy of SCM in Rett syndrome. Methods: A retrospective study to assess the clinical efficacy of SSEP SCM in Rett syndrome patients undergoing scoliosis surgery. Somatosensory-evoked potentials were monitored in 7 patients (8 procedures) with Rett syndrome undergoing scoliosis surgery. Transcranial motor-evoked potentials were not performed because of a concomitant history of seizures. The specific methods of anesthesia and SSEP monitoring were standardized for all patients. Results: Adequate baseline and intraoperative SSEP measurements could be obtained in all patients. There were no false-negative or false-positive results. There were 7 true-negative and 1 true-positive results during surgery. The latter was a signal amplitude decrease that did not immediately resolve with standard interventions. Consequently, a Stagnara wake-up test was performed that showed spontaneous muscle activity in both lower extremities. No intravenous steroids were given, and the procedure was completed. The patient had transient unilateral lower extremity motor weakness postoperatively, but recovered preoperative muscle function within 24 hours. Conclusions: Patients with Rett syndrome undergoing scoliosis surgery can be successfully monitored with SSEPs. A history of seizures is a relative contraindication to transcranial motor-evoked potentials. Monitoring can accurately alert the surgeon to potential intraoperative spinal cord compromise and, therefore, decrease postoperative morbidity.
R ett syndrome is a neurodevelopmental disorder that primarily affects females. The estimated prevalence is 1 per 22,800 females. 1 The syndrome is caused by a mutation in the MECP2 gene that encodes for methyl CpG binding protein 2.
2 This protein is expressed most abundantly in the brain, where it is largely responsible for normal synaptogenesis. 2 Affected individuals typically appear normal at birth. However, starting at approximately 6 months of age, the natural history of the disease begins to emerge in the first of 4 stages of progression. 3 Stage 1 consists of developmental arrest that may begin anywhere from 6 to 18 months of age. The first sign may be deceleration of head growth. 4 Infants may also appear placid with decreased eye contact and decreased playing. Affected children also develop nonspecific hand-wringing gestures. Stage 2 consists of developmental regression that begins between 1 and 4 years of age. This stage is marked by the loss of acquired fine motor skills, especially purposeful hand movements. In place of these movements, children develop their own idiosyncratic stereotyped hand movements such as hand-to-mouth licking or intermittent grasping of hair or clothing. Children also demonstrate periodic breathing abnormalities, loss of communication skills, including spoken language, loss of interest in surroundings, and abrupt unprecipitated episodes of inconsolable screaming that may last for hours and can disturb sleep. Stage 3 is a pseudostationary phase that may begin between 2 and 10 years of age. During this stage, children may have modest recovery of nonverbal communication skills (eg, better eye contact) and hand use. However, at the same time, they typically sustain a decrease in motor function and the development of epileptic seizures. Epilepsy develops in approximately 94% of patients at a mean age of 4 years, and only 46% of the resultant seizures can be effectively controlled by medication. 5 Stage 4 consists of progressive motor deterioration that usually begins after 10 years of age. This stage is marked by increased rigidity, dystonia, and bradykinesia, which all contribute to decreased mobility. Children typically show signs of scoliosis during this stage. Scoliosis develops in 50% to 70% of these patients by 8 to 11 years of age.
6Y8 Furthermore, it often progresses, requiring surgery.
8Y10 Specific indications for surgery include curve progression to greater than 40 to 45 degrees or a curve that causes pain or loss of function.
11
In scoliosis surgery for any diagnosis, intraoperative spinal cord injury and resultant neurological deficit are the most feared complication with a reported incidence of 0.25% to 3.2%. 12Y15 The actual incidence among patients with Rett syndrome is unknown. To decrease the incidence of this complication, continuous intraoperative spinal cord monitoring (SCM) is used. This has been studied and applied to patients with a wide variety of diagnoses with scoliosis. Idiopathic scoliosis (IS) and specific neuromuscular scoliosis (NMS) patients have been shown to significantly benefit from multimodal intraoperative SCM. Recording somatosensoryevoked potentials (SSEPs) allows for monitoring of the dorsal columnYmedial lemniscus sensory pathways, and recording transcranial motor-evoked potentials (TcMEPs) allows for monitoring of the anterior corticospinal motor pathways. 16, 17 Using this multimodal approach, 95% to 96% of NMS patients can be monitored effectively. 18, 19 However, the specific etiology of NMS can negatively affect the reliability of multimodal monitoring. In particular, the success of monitoring cerebral palsy (CP), the most common NMS disorder, is inversely proportional to the severity of their underlying deficit. Reliable SSEPs can be obtained in 82% of CP-related NMS patients, and reliable TcMEPs can be obtained in 63% with mild or moderate CP compared with only 39% of those with severe CP. Furthermore, CP-related NMS patients as a whole are more difficult to monitor than non-CPYrelated NMS patients. In non-CPYrelated NMS patients, reliable SSEPs can be obtained in 86% (vs 82% of CP-related NMS patients), and reliable TcMEPs can also be obtained in 86% (vs 39%Y63% of CP-related NMS patients). 20 Finally, almost all IS patients can be monitored reliably.
In contrast to CP-related NMS patients and many nonCPYrelated NMS patients, Rett syndrome patients typically cannot be monitored with a multimodal approach. A history of seizures is a relative contraindication to TcMEP monitoring because of the possibility of inducing an intraoperative seizure. 21, 22 Therefore, these patients are typically monitored with SSEPs alone, which may be of limited clinical use. Monitoring SSEPs alone in the context of NMS has been shown to yield inconsistent results in some studies. Specifically, responses may be absent at baseline, and/or the response amplitude may be too small or variable to allow for reliable monitoring. 23, 24 This variability may be present in up to 28% of NMS patients. 23 Furthermore, several case reports have shown that SSEPs alone can be ineffective in detecting motor tract deficits, leading to serious false-negative results.
25Y28
However, there have been no studies that specifically evaluated the efficacy and accuracy of SCM in Rett syndrome.
METHODS
This study was approved by our institutional review board. Seven patients (8 procedures) with Rett syndrome who underwent scoliosis surgery and had SCM were identified from the Pediatric Orthopaedic Spine Database (1992Y2007). All were monitored with SSEPs using a standardized general anesthesia technique and monitoring protocol between November 1997 and January 2007. There were 10 additional Rett patients who had spinal surgery for scoliosis during this time who did not undergo SCM as they did not meet our existing criteria for intraoperative SCM. Our general criterion for SCM in NMS has been a patient who was ambulatory, with or without assistance, or relatively continent of bowel and bladder function, or both. In all cases, the upper and lower extremities were monitored with SSEPs. The ulnar nerve was stimulated at the cubital tunnel, and the tibial nerve was stimulated at the medial malleolus. Disposable pregelled patch electrodes were used (Nicolet), and stimulation was achieved with a constant current of 50 mA, a stimulus rate of 4.7 Hz, and a duration of 0.3 milliseconds. The TcMEP was not attempted because all 7 patients had a seizure disorder.
Responses were recorded using subdermal needle electrodes across the somatosensory cortex according to the international 10Y20 system. 29 Subcortical responses were obtained from the cervical spine, and peripheral responses were obtained bilaterally from the popliteal fossae using subdermal needle electrodes. A minimum of 300 trials was averaged, and filters were set at 100 to 2000 Hz for the cervical sites and between 50 and 500 Hz at the popliteal fossae. Amplifier sensitivity ranged from 0.2 KV to 1.0 KV.
Baseline SSEP values were obtained after exposure but before instrumentation, allowing anesthetic levels and core temperature to stabilize to provide a more reliable point of reference. 30, 31 Baseline values were considered reliable if recognizable and reproducible waveforms could be obtained. After obtaining baseline values, lower extremity recordings were taken every 5 to 10 minutes, and upper extremity recordings were taken every 30 minutes throughout surgery. Spontaneous electromyograms were also monitored from the left and right quadriceps and tibialis anterior muscles. Finally, all pedicle screws were stimulated to 15 mA without concomitant electromyogram recordings.
A significant change from baseline was defined as a decrease in amplitude greater than 50% and/or an increase in latency of greater than 10%.
18,31Y39 Between these 2 criteria, amplitude changes were considered more sensitive to the onset of injury, but both criterion were used for thoroughness. 32 If a significant change was encountered, then both the surgeon and anesthesiologist were notified immediately. Initially, the anesthesiologist corrected any hemodynamic disturbances such as hypotension and hypothermia. If these corrections did not bring recordings back to baseline, then the surgeon would reverse the most likely inciting operative step. If significant change continued to persist, then a Stagnara wake-up test was performed. 40 The Stagnara wake-up test was considered negative if the patient moved their lower extremities appropriately to command. The Stagnara wake-up test was considered positive if the patient demonstrated any changes in motor function in the lower extremities.
The preoperative characteristics and the operative and postoperative courses of each patient were then retrospectively reviewed to evaluate the efficacy of this approach.
Demographic data, diagnoses, preoperative neurological status, surgical procedure, surgical time, estimated blood loss, the ability to obtain baseline SSEP values, the presence of significant deviations from baseline recordings, the use of the Stagnara wake-up test, and postoperative neurological status were all recorded.
Primary outcome measures included the ability to obtain baseline values, the percentage of patients who maintained their preoperative level of motor function, and monitoring results that were divided into 4 categories. A false-positive result was defined as monitoring data that showed significant change (as defined previously) that did not return to normal with reversal of operative maneuvers but also did not result in a new neurological deficit on the Stagnara wake-up test or after surgery. A false-negative result was defined as monitoring data that remained consistent with baseline values throughout the procedure, but the patient demonstrated a new neurological deficit after surgery. A true-positive result was defined as monitoring data that showed a significant change that either returned to baseline with reversal of an operative maneuver or resulted in a new neurological deficit on the Stagnara wake-up test and/or a new neurological deficit after surgery. A true-negative result was defined as monitoring data that remained consistent with baseline values throughout the procedure and correlated with unchanged neurological status after surgery.
RESULTS
The clinical and radiographic data for the 7 patients is presented in the Table 1 . The procedures consisted of posterior spinal fusion and segmental spinal instrumentation (n = 6) or short apical anterior and posterior fusion and submuscular rod placement who after several lengthenings underwent a final posterior spinal fusion and segmental spinal instrumentation (n = 1). Only the initial insertion and final fusion procedures for this patient had SCM. These 7 patients met our criteria for SCM. All had a seizure disorder. The mean age at surgery was 11.75 years (range, 3Y17 years). The mean preoperative curve was 58.1 degrees (range, 42Y106 degrees), and the mean postoperative curve was 25.6 degrees (range, 15Y42 degrees). Thus, the mean postoperative correction was 32.5 degrees (range, 11Y66 degrees) or 54% correction (range, 26%Y85%). The mean operative time was 280 minutes (range, 145Y375 minutes). The mean perioperative blood loss (estimated intraoperative and postoperative suction drainage) was 536 mL (range, 100Y1150 mL). All patients received Amicar intraoperatively to minimize perioperative blood loss.
Baseline SSEPs were obtainable in all 7 patients. Intraoperatively, there were 7 true-negative monitoring results, 1 true-positive result, and no false-negative or false-positive results. Postoperative neurological function was consistent with preoperative neurological function in all patients. For the single case with a true-positive result, recordings demonstrated a 50% decrease in signal amplitude after the tightening of sublaminar wires. Mild hypotension and hypothermia occurred at the time of monitoring changes. The hypotension and hypothermia were corrected, but the signal amplitude decrease persisted. Consequently, the sublaminar wires were loosened temporarily and a Stagnara wake-up test was performed. The patient demonstrated active motion in both lower extremities and feet and was felt to be neurologically intact. No intraoperative steroids were given, and the procedure was completed. The patient demonstrated mild unilateral lower extremity weakness upon recovery from anesthesia but regained her preoperative muscle function within 24 hours postoperatively.
Two additional patients had complications. One had a small dural tear that was repaired intraoperatively. This patient also had a small postoperative pleural effusion that was observed and resolved spontaneously. The remaining patient had a postoperative atelectasis that resolved with medical treatment.
DISCUSSION
Intraoperative SCM during spinal surgery is a widely accepted technique with proven clinical efficacy. More specifically, multimodal monitoring is becoming the standard of care for IS and many NMS patients. The combination of both SSEPs and TcMEPs versus either method alone provides greater reliability and sensitivity because each method has its own set of strengths and weaknesses.
In particular, SSEPs may be influenced by anesthetic agents, muscle relaxants, mean arterial pressure, and hypothermia. 41, 42 These factors may lead to high false-positive rates if SSEP monitoring is used alone. 43 In addition, SSEP monitoring only assesses the dorsal columnYmedial lemniscus sensory pathways, perfused by the radicular arteries, 44 but it fails to monitor the anterior motor pathways. Consequently, SSEP monitoring alone may also lead to falsenegative results. 26, 27 In contrast, TcMEPs tend to be less variable than SSEPs, but they may be more influenced by anesthetic agents. 45 The TcMEP monitoring only assesses the anterior corticospinal motor pathways, perfused by the anterior spinal artery, but it fails to monitor the posterior sensory pathways. However, the preservation of motor function is far more crucial than that of sensory function. Nonetheless, a combination of both techniques consistently provides the best outcomes for patients undergoing spinal deformity surgery.
The use of multimodal monitoring has been studied in several different populations of scoliosis patients including IS, CP-related NMS, and non-CPYrelated NMS. Among these groups of patients, IS patients demonstrate the most reliable monitoring followed by patients with non-CPYrelated NMS, mild CP-related NMS, moderate CP-related NMS, and finally, severe CP-related NMS. Rett syndrome patients fit into the non-CPYrelated NMS category, but unlike some other forms of non-CPYrelated NMS, Rett syndrome patients typically have a history of seizures, which is a relative contraindication to the use of TcMEP monitoring. Other relative contraindications to TcMEP include cardiac disease, cardiac pacemakers or other implanted biomedical devices, vascular clamps or shunts, cortical lesions, convexity skull defects, prior craniotomy, proconvulsant medications or anesthetics, and raised intracranial pressure. 21, 22 However, with appropriate precautions, the benefits of TcMEP in scoliosis surgery in NMS patients may outweigh the associated risks. 21, 22 Despite this limitation, spine surgeons performing scoliosis surgery on Rett syndrome patients should consider monitoring these patients with SSEPs because this type of monitoring can be accurately performed. Preliminary evidence for the efficacy of unimodal monitoring outlined in this series has been promising, but larger prospective studies may be needed to fully elucidate the role of unimodal monitoring in this select patient population. We now recommend that it be used on all Rett syndrome patients regardless of their preoperative functional level. Whether TcMEP should be used concomitantly remains controversial.
